The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|5|3|239-248

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.5, Iss.3, 2007-07, pp. : 239-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelin-1 and Endothelin Converting Enzyme-1 in Human Atherosclerosis - Novel Targets for Pharmacotherapy in Atherosclerosis

By  

Current Vascular Pharmacology, Vol. 2, Iss. 3, 2004-07 ,pp. : 249-258

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Method of Forceps Biopsy Improves the Diagnosis of Proximal Biliary Malignancies

By Kulaksiz Hasan   Strnad Pavel   Römpp Achim   Figura Guido   Barth Thomas   Esposito Irene   Schirmacher Peter   Henne-Bruns Doris   Adler Guido   Stiehl Adolf  

Digestive Diseases and Sciences, Vol. 56, Iss. 2, 2011-02 ,pp. : 596-601

Springer Publishing Company

Access to resources Recommend Favorite

Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development

By Becker Richard  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 2, 2007-04 ,pp. : 159-161

Springer Publishing Company

Access to resources Recommend Favorite

Endothelin-1 Actions on Vascular Smooth Muscle Cell Functions As a Target for the Prevention of Atherosclerosis

By  

Current Vascular Pharmacology, Vol. 6, Iss. 3, 2008-07 ,pp. : 195-203

Bentham Science Publishers

Access to resources Recommend Favorite

Ryanodine Receptor - A Novel Therapeutic Target in Heart Disease

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 110-118

Bentham Science Publishers

Access to resources Recommend Favorite